Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

More than half of Ozempic users prescribed the drug for obesity alone are stopping or reducing their doses within a year, ...

AbbVie has unveiled the first data from its $350 million obesity bet, with the amylin analog demonstrating weight loss of close to 10% after 12 weeks in one dose cohort.

In this video, Camilla W. Kilbane, MD, discusses how to approach monitoring patients after they initiate treatment for tardive dyskinesia.

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present two posters featuring real-world data from its ...

Lucy Lazarony is an experienced personal finance journalist and writer who got her start in 1998 writing about financial topics. She writes accessible and easy-to-understand articles about credit, ...

Pills, injections, and the newest obesity drugs on the way – What they promise, what they deliver, and how safe they are ...

In another forum, a poster pointed out that AIs are tweaked, even before release, to reduce errors and inappropriate results. AIs are constrained-guessing devices. Ordinary language rules for ...

PCWorld reports that Windows 11 update KB5077181 is causing critical boot loops and login failures for users after installation. The problematic February update ...

Science is a subject built on doing. Students learn chemistry through titrations, biology through dissections, physics through motion experiments, and earth science through field observations. That ...

A peer-reviewed study of more than 46,000 older adults with type 2 diabetes found that patients who started GLP-1 receptor agonist drugs faced an 11 percent higher risk of fragility fractures compared ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study ...